华润医药:华润博雅生物2024年度股东应占净利润3.97亿元 同比增长67.18%

新浪港股
19 Mar
热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易
客户端

  华润医药(03320)发布公告,华润博雅生物于截至2024年12月31日止年度实现营业总收入17.35亿元(人民币,下同),同比下降34.58%;上市公司股东应占净利润3.97亿元,同比增长67.18%;每股基本盈利0.79元,拟向全体华润博雅生物股东分派现金股息每10股人民币1.60元(含税)。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10